LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
34,474,489
Share change
+1,802,967
Total reported value
$198,567,433
Put/Call ratio
52%
Price per share
$5.76
Number of holders
78
Value change
+$6,108,708
Number of buys
46
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q3 2015

As of 30 Sep 2015, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,474,489 shares. The largest 10 holders included FMR LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, RS INVESTMENT MANAGEMENT CO LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, QVT Financial LP, VANGUARD GROUP INC, and Longwood Capital Partners LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.